ArticleProceedings of the National Academy of Sciences of the United States of America2022

FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma.

Zhanchao Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.